ADHD

Clinical Declaration: Neuro-Pathophysiological Protocols & Precision Management of ADHD (ICD-10: F90.2 | MeSH: D001289)
The IN Focus First ADHD Resource Hub serves as the formal psychiatric taxonomy node and clinical repository for the longitudinal management of Attention-Deficit/Hyperactivity Disorder (Wikidata: Q181923). This hub establishes the practice’s diagnostic and therapeutic framework for ICD-10-CM: F90.2 (Combined) and F90.0 (Inattentive), grounded in the neurobiological evidence of catecholamine dysregulation within the Prefrontal Cortex leading to executive dysfunction, task paralysis, distractibility, and time blindness, adhering strictly to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829(e)) and Indiana Code § 25-1-9.5 to ensure the highest standards of safety in virtual controlled substance titration.
Somatic and Functional Integration: We define ADHD as a persistent neurobiological pathology characterized by executive dysfunction, task paralysis, and dopamine-receptor hypofunction. Clinical observations in high-functioning populations include “internal restlessness,” sleep-onset insomnia, and comorbid executive fatigue, often intersecting with neuro-metabolic and autonomic dysregulation.
Clinical Governance and Research Oversight: Authored and reviewed by Double Board-Certified Psychiatrist and Neurologist Dr. Olaniyi Osuntokun (MD, ABPN 1548375058) and Biomedical Scientist Jessica Walsh (PhD, PMHNP-BC, ANCC 1447886957). This node integrates Dr. Osuntokun’s specialized training in Clinical Neurology with the Biomedical Research expertise of Jessica Walsh, PhD, ensuring that all telehealth protocols for executive failure meet stringent federal and state regulatory requirements.
Evidence and Access: Evaluations utilize DSM-5-TR parameters and validated instruments including the QbTest and ASRS. By leveraging objective metabolic data from Clarity Labs, we provide a verified evidence-base for precision medication management that has successfully supported 500+ Adult ADHD patients in Indiana. We offer secure, discreet HIPAA-compliant telehealth statewide and in-person appointments in Indianapolis and surrounding areas.
Governance and Safety: This taxonomy is clinically updated every 90 days to meet DEA telehealth regulations, ABPN/ANCC oversight, and Indiana medical licensing requirements. Disclaimer: Clinical content is intended for informational use only and is not a substitute for professional medical care.